Morgan Stanley Stock News

In todays roundup of regional news headlines, Morgan Stanley enters a deal to help develop a logistics park near Mumbai, HSBC agrees to buy an Indian mutual fund business to expand its asset management business on the subcontinent, and Chinese Read More>> The post Morgan Stanley Launches $80M India Logistics JV and More Asia Real Estate Headlines appeared first on Mingtiandi .

The investment comes right after Fast&Up raised its series C funding of $22 million (around ₹165 crore) from Morgan Stanley Private Equity Asia

Celularity Inc (NASDAQ:CELU)s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $4.39 and last traded at $4.58, with a volume of 1352 shares trading hands. The stock had previously closed at $4.72. Several research firms have recently weighed in on CELU. Morgan Stanley began []

CVS Health (NYSE:CVS) had its price objective increased by Tigress Financial from $108.00 to $122.00 in a research note released on Thursday morning, Analyst Ratings Network reports. They currently have a buy rating on the pharmacy operators stock. A number of other analysts have also recently weighed in on CVS. Morgan Stanley upped their target []

Paychex (NASDAQ:PAYX) had its target price lifted by Morgan Stanley from $105.00 to $135.00 in a research report sent to investors on Thursday, Analyst Ratings Network reports. Morgan Stanley currently has an equal weight rating on the business services providers stock. A number of other brokerages have also issued reports on PAYX. Deutsche Bank Aktiengesellschaft [] The post Paychex (NASDAQ:PAYX) Price Target Increased to $135.00 by Analysts at Morgan Stanley appeared first on ETF Daily News .

Mizuho reiterated their buy rating on shares of Arcutis Biotherapeutics (NASDAQ:ARQT) in a report issued on Thursday morning, TipRanks reports. They currently have a $58.00 price target on the stock. A number of other research firms have also commented on ARQT. Morgan Stanley lowered their price objective on shares of Arcutis Biotherapeutics from $50.00 to []

Abbott Laboratories (NYSE:ABT) had its price target lowered by Raymond James from $150.00 to $134.00 in a research note released on Thursday. ABT has been the topic of several other research reports. Morgan Stanley upped their price objective on Abbott Laboratories from $136.00 to $146.00 and gave the company an overweight rating in a research []

NextEra Energy (NYSE:NEE) had its price target lifted by Morgan Stanley from $82.00 to $84.00 in a research note published on Tuesday morning, PriceTargets.com reports. The firm currently has an equal weight rating on the utilities providers stock. NEE has been the subject of a number of other research reports. BMO Capital Markets increased their [] The post NextEra Energy (NYSE:NEE) Price Target Raised to $84.00 at Morgan Stanley appeared first on ETF Daily News .

Eversource Energy (NYSE:ES) had its target price lifted by Morgan Stanley from $85.00 to $90.00 in a report released on Tuesday morning, Analyst Price Targets reports. Morgan Stanley currently has an equal weight rating on the utilities providers stock. Other research analysts have also recently issued research reports about the company. Wells Fargo & Company []

Edison International (NYSE:EIX) had its target price upped by Morgan Stanley from $57.00 to $61.00 in a research note issued to investors on Tuesday morning, Analyst Price Targets reports. They currently have an equal weight rating on the utilities providers stock. Separately, Wells Fargo & Company reduced their price objective on shares of Edison International []

Fangdd Network Group Ltd. (NASDAQ:DUO) shares fell 1.9% during mid-day trading on Thursday . The stock traded as low as $0.49 and last traded at $0.52. 361,314 shares traded hands during trading, a decline of 34% from the average session volume of 550,629 shares. The stock had previously closed at $0.53. Separately, Morgan Stanley downgraded []

Koninklijke KPN (OTCMKTS:KKPNY) has been assigned a consensus recommendation of Buy from the eight ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. KKPNY has been the topic of several analyst reports. Morgan Stanley reiterated []

O Neil Global Advisors Inc. lowered its holdings in shares of Morgan Stanley (NYSE:MS) by 28.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 4,318 shares of the financial services providers stock after selling 1,682 shares during the period. O Neil Global Advisors Inc.s holdings in Morgan []

Morgan Stanley (NYSE:MS) Equities research analysts at Oppenheimer lifted their Q1 2022 earnings estimates for Morgan Stanley in a report issued on Wednesday, December 22nd. Oppenheimer analyst C. Kotowski now anticipates that the financial services provider will post earnings of $1.95 per share for the quarter, up from their previous estimate of $1.93. Oppenheimer []

Redhawk Wealth Advisors Inc. bought a new position in iShares MSCI KLD 400 Social ETF (NYSEARCA:DSI) in the 3rd quarter, Holdings Channel.com reports. The firm bought 4,149 shares of the companys stock, valued at approximately $345,000. A number of other large investors also recently made changes to their positions in the stock. Morgan Stanley raised []